Dr. Aristotelis Theodore Laliotis, MD

Dr. Laliotis practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Laliotis' NPI, 1124076435, was assigned on May 5, 2006. Dr. Laliotis graduated from UC San Diego School of Medicine in 1994. Dr. Laliotis holds California license A054580.

Dr. Laliotis' primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Laliotis' primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Laliotis is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Laliotis to 2 more home health agencies, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laliotis practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Laliotis' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Laliotis is board certified in internal medicine by the American Board of Internal Medicine. Dr. Laliotis is licensed in California.

Dmand AI lists acute kidney failure, acute mini-stroke (TIA), acute sinusitis, acute skin infection, aneurysm, ankle or foot injury, anxiety and aortic atherosclerois among the conditions Dr. Laliotis treats.

CMS data shows 807 Medicare services from Dr. Laliotis across 12 procedure codes in 2024, for 313 Medicare patients. Medicare paid $69,433 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Dr. Laliotis in 2024. The largest group is 65 to 74, with 143 patients. 71% of them have high cholesterol, and 61% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Laliotis' median patient age at 62, with 38% women.

In 2024, Dr. Laliotis wrote 7,729 Medicare Part D claims for 747 patients. 85% of them were for generic drugs. CMS names the drug for 6,884 of them, across 139 drugs with 11 or more claims each, at $959,161 in total drug cost. In 2023, CMS named 6,194 claims across 133 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Laliotis for performance year 2024, reported as part of a group. Dr. Laliotis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Laliotis as offering telehealth. CMS counts 19 procedures of removal of skin lesions by Dr. Laliotis, more than 64% of the clinicians it reports for that procedure.

CMS Open Payments shows 33 general payments to Dr. Laliotis from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Novo Nordisk Inc paid the most, $591.

Dmand AI lists 1 award for Dr. Laliotis, most recently CMS Stage 1 EHR in 2013.

Dr. Laliotis graduated from UC San Diego School of Medicine in 1994. Dr. Laliotis is a member of ACP.

Dr. Laliotis is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.